A Guide For Multicentre Trials in High-Burden Countries
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis.
Accessed in November 2017.
O presente Manual realça aspectos desde o diagnóstico e o manuseio dos casos até às medidas a serem tomadas de modo a reduzir a transmissão da tuberculose na
comunidade. Este manual foi desenvolvido para orientar os clínicos e outros profissionais de saúde na gestão dos casos de tuberculose... resistente, desde o nível periférico até ao nível central.
more
Global HIV control funding falls short of need. To maximize health outcomes, it is critical that national governments sustain reasonable commitments, and that international donor assistance be distributed according to country needs and funding gaps. We develop a country classification framework in t...erms of actual versus expected national domestic funding, considering resource needs and donor financing. With UNAIDS and World Bank data, we examine domestic and donor HIV program funding in relation to need in 84 low- and middle-income countries. We estimate expected domestic contributions per person living with HIV (PLWH) as a function of per capita income, relative size of the health sector, and per capita foreign debt service.
more
the Lancet Infectious Diseases Published online March 22, 2022 https://daoi.org/10.1016/S1473-3099(22)00214-6
Report of a mission 20–24 April 2015
Training leaders in public health
IMDP 2016 Training Catalogue
N Engl J Med 2022; 386:911-922, DOI: 10.1056/NEJMoa2104535
Four months of antituberculosis treatment was noninferior to 6 months of treatment in children with drug-susceptible, nonsevere, smear-negative tuberculosis (SHINE Study)
Update 2021; Immunization, Vaccines and Biologicals
Epidemiologisches Bulletin; 22. August 2016 / Nr. 33 ;DOI 10.17886/EpiBull-2016-050